{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:07:44Z","timestamp":1779246464108,"version":"3.51.4"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014269","name":"Uniwersytet Medyczny w Bia\u0142ymstoku","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005297","name":"Medical University of Bialystok","doi-asserted-by":"publisher","award":["B.SUB.25.180"],"award-info":[{"award-number":["B.SUB.25.180"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biopha.2026.119241","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:53:33Z","timestamp":1774929213000},"page":"119241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cancer cell migration under control of human cathelicidin LL-37"],"prefix":"10.1016","volume":"198","author":[{"given":"Konrad","family":"\u017bochowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Sadowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewelina","family":"Piktel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Pogoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Bucki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119241_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41576-022-00553-x","article-title":"Spatial biology of cancer evolution","volume":"24","author":"Seferbekova","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biopha.2026.119241_bib2","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119241_bib3","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1111\/febs.16046","article-title":"The gate to metastasis: key players in cancer cell intravasation","volume":"289","author":"Sznurkowska","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2026.119241_bib4","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1136\/gutjnl-2014-308935","article-title":"Microenvironmental hCAP-18\/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment","volume":"64","author":"Sainz","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2026.119241_bib5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1183\/09031936.00080806","article-title":"Release of the antimicrobial peptide LL-37 from DNA\/F-actin bundles in cystic fibrosis sputum","volume":"29","author":"Bucki","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2026.119241_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00005-009-0057-2","article-title":"Cathelicidin LL-37: A multitask antimicrobial peptide","volume":"58","author":"Bucki","year":"2010","journal-title":"Arch. Immunol. Et. Ther. Exp."},{"key":"10.1016\/j.biopha.2026.119241_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10060650","article-title":"The potential of human peptide ll-37 as an antimicrobial and anti-biofilm agent","volume":"10","author":"Ridyard","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.biopha.2026.119241_bib8","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI17545","article-title":"An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18","volume":"111","author":"Koczulla","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2026.119241_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120891","article-title":"Enhancing the anticancer efficacy of a LL-37 peptide fragment analog using peptide-linked PLGA conjugate micelles in tumor cells","volume":"606","author":"Mori","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119241_bib10","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.peptides.2011.06.005","article-title":"Wound healing activity of the human antimicrobial peptide LL37","volume":"32","author":"Ramos","year":"2011","journal-title":"Pept. (N. Y. )."},{"key":"10.1016\/j.biopha.2026.119241_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137443","article-title":"Sphingosine-1-Phosphate-Triggered Expression of Cathelicidin LL-37 Promotes the Growth of Human Bladder Cancer Cells","volume":"23","author":"Wollny","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119241_bib12","article-title":"Significance of LL-37 on Immunomodulation and Disease Outcome","volume":"2020","author":"Yang","year":"2020","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.biopha.2026.119241_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.semcdb.2018.04.006","article-title":"Human antimicrobial peptides and cancer","volume":"88","author":"Jin","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119241_bib14","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.bbamem.2006.03.030","article-title":"LL-37, the only human member of the cathelicidin family of antimicrobial peptides","volume":"1758","author":"D\u00fcrr","year":"2006","journal-title":"Biochim. Et. Biophys. Acta Biomembr."},{"key":"10.1016\/j.biopha.2026.119241_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00005-015-0359-5","article-title":"The Role of Cathelicidin LL-37 in Cancer Development","volume":"64","author":"Piktel","year":"2016","journal-title":"Arch. Immunol. Et. Ther. Exp."},{"key":"10.1016\/j.biopha.2026.119241_bib16","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/eji.200939275","article-title":"The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils","volume":"40","author":"Alalwani","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2026.119241_bib17","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1080\/02713683.2017.1339806","article-title":"Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry","volume":"42","author":"Manarang","year":"2017","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.biopha.2026.119241_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mrrev.2011.05.002","article-title":"Initial steps of metastasis: Cell invasion and endothelial transmigration","volume":"728","author":"Van Zijl","year":"2011","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"10.1016\/j.biopha.2026.119241_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: Molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119241_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial\u2013mesenchymal transition","volume":"21","author":"Yang","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119241_bib21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrc1075","article-title":"Tumour-cell invasion and migration: Diversity and escape mechanisms","volume":"3","author":"Friedl","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119241_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1363361","article-title":"Plasticity in cell migration modes across development, physiology, and disease","volume":"12","author":"Pourjafar","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119241_bib23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.tcb.2015.06.003","article-title":"Collective cell migration: Guidance principles and hierarchies","volume":"25","author":"Haeger","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.biopha.2026.119241_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02338-2","article-title":"Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025","volume":"24","author":"Allgayer","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2026.119241_bib25","doi-asserted-by":"crossref","unstructured":"Eddy, C.Z., Raposo, H., Wong, R. & Sun, B. Morphodynamics Facilitate Cancer Cells to Navigate 3D Extracellular Matrix. (2021) doi:10.1038\/s41598-021-99902-9.","DOI":"10.1038\/s41598-021-99902-9"},{"key":"10.1016\/j.biopha.2026.119241_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119241_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-023-05554-y","article-title":"Durotaxis and negative durotaxis: where should cells go?","volume":"6","author":"Ji","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.biopha.2026.119241_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-50227-9","article-title":"Automated tracking of cell migration in phase contrast images with CellTraxx","volume":"13","author":"Holme","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119241_bib29","doi-asserted-by":"crossref","DOI":"10.3791\/51046-v","article-title":"vitro cell migration and invasion assays","author":"Justus","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2026.119241_bib30","doi-asserted-by":"crossref","first-page":"13763","DOI":"10.1021\/acs.langmuir.4c05135","article-title":"Directing Cell Phenotype: Quantitative Single-Cell Migration Assay Leveraging Tunable Extracellular Surfaces","volume":"41","author":"Kaler","year":"2025","journal-title":"Langmuir"},{"key":"10.1016\/j.biopha.2026.119241_bib31","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jid.2016.11.020","article-title":"Research Techniques Made Simple: Analysis of Collective Cell Migration Using the Wound Healing Assay","volume":"137","author":"Grada","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2026.119241_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2019.00107","article-title":"vitro cell migration, invasion, and adhesion assays: From cell imaging to data analysis","volume":"7","author":"Pijuan","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119241_bib33","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00018-012-1115-1","article-title":"Tumor cell migration in complex microenvironments","volume":"70","author":"Polacheck","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119241_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15215284","article-title":"Exploring Cell Migration Mechanisms in Cancer: From Wound Healing Assays to Cellular Automata Models","volume":"15","author":"Migliaccio","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2026.119241_bib35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.yexcr.2019.01.011","article-title":"Migration versus proliferation as contributor to in vitro wound healing of vascular endothelial and smooth muscle cells","volume":"376","author":"Ammann","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2026.119241_bib36","article-title":"Cell Migration\u2013Proliferation Dichotomy in Cancer: Biological Fact or Experimental Artefact?","volume":"13","author":"Alfahed","year":"2024","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.biopha.2026.119241_bib37","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.bpj.2020.01.036","article-title":"Examining Go-or-Grow Using Fluorescent Cell-Cycle Indicators and Cell-Cycle-Inhibiting Drugs","volume":"118","author":"Vittadello","year":"2020","journal-title":"Biophys. J."},{"key":"10.1016\/j.biopha.2026.119241_bib38","doi-asserted-by":"crossref","first-page":"14135","DOI":"10.1038\/s41598-017-14458-x","article-title":"Quantitative label-free single cell tracking in 3D biomimetic matrices","volume":"7","author":"Sapudom","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119241_bib39","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevLett.98.118101","article-title":"Migration and proliferation dichotomy in tumor-cell invasion","volume":"98","author":"Fedotov","year":"2007","journal-title":"Phys. Rev. Lett."},{"key":"10.1016\/j.biopha.2026.119241_bib40","doi-asserted-by":"crossref","DOI":"10.1063\/1.5019196","article-title":"Anomalously diffusing and persistently migrating cells in 2D and 3D culture environments","volume":"2","author":"Luzhansky","year":"2018","journal-title":"APL Bioeng."},{"key":"10.1016\/j.biopha.2026.119241_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nprot.2015.030","article-title":"Statistical analysis of cell migration in 3D using the anisotropic persistent random walk model","volume":"10","author":"Wu","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2026.119241_bib42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.trecan.2017.04.008","article-title":"Migrastatics\u2014Anti-metastatic and Anti-invasion Drugs: Promises and Challenges","volume":"3","author":"Gandalovi\u010dov\u00e1","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biopha.2026.119241_bib43","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41416-021-01442-6","article-title":"A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma","volume":"125","author":"Maiques","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119241_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06494-6","article-title":"Curvotaxis directs cell migration through cell-scale curvature landscapes","volume":"9","author":"Pieuchot","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119241_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18950-x","article-title":"Tumor spheroids accelerate persistently invading cancer cells","volume":"12","author":"Audoin","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119241_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006961","article-title":"Physical constraints on accuracy and persistence during breast cancer cell chemotaxis","volume":"15","author":"Varennes","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.biopha.2026.119241_bib47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cell.2015.01.056","article-title":"Actin flows mediate a universal coupling between cell speed and cell persistence","volume":"161","author":"Maiuri","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119241_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphy.2021.719293","article-title":"Random Walks of a Cell With Correlated Speed and Persistence Influenced by the Extracellular Topography","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Phys."},{"key":"10.1016\/j.biopha.2026.119241_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06563-w","article-title":"L\u00e9vy-like movement patterns of metastatic cancer cells revealed in microfabricated systems and implicated in vivo","volume":"9","author":"Huda","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119241_bib50","article-title":"The Random Walk\u2019s Guide to Anomalous Diffusion: A Fractional Dynamics Approach","volume":"339","author":"Metzler","year":"2000","journal-title":"J. Klafter). Phys. Rep."},{"key":"10.1016\/j.biopha.2026.119241_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1142\/S1793048014500052","article-title":"Continuous time random walk and migration-proliferation dichotomy of brain cancer","volume":"10","author":"Iomin","year":"2015","journal-title":"Biophys. Rev. Lett."},{"key":"10.1016\/j.biopha.2026.119241_bib52","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1098\/rsif.2008.0014","article-title":"Random walk models in biology","volume":"5","author":"Codling","year":"2008","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.biopha.2026.119241_bib53","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1529\/biophysj.105.061150","article-title":"Cell motility as persistent random motion: Theories from experiments","volume":"89","author":"Selmeczi","year":"2005","journal-title":"Biophys. J."},{"key":"10.1016\/j.biopha.2026.119241_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-02804-3","article-title":"Anisotropic persistent random walk model simulates T-cells migration over curved landscapes","volume":"15","author":"Carlin","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119241_bib55","doi-asserted-by":"crossref","DOI":"10.1007\/BF00275919","article-title":"Biased Random Walk Models for Chemotaxis and Related Diffusion Approximations","volume":"9","author":"Alt","year":"1980","journal-title":"J. Math. Biol."},{"key":"10.1016\/j.biopha.2026.119241_bib56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00285-008-0201-3","article-title":"A user\u2019s guide to PDE models for chemotaxis","volume":"58","author":"Hillen","year":"2009","journal-title":"J. Math. Biol."},{"key":"10.1016\/j.biopha.2026.119241_bib57","doi-asserted-by":"crossref","unstructured":"Kraning-Rush, C.M., Carey, S.P., Lampi, M.C., Reinhart-King, C.A. & Reinhart, C.A. Microfabricated collagen tracks facilitate single cell metastatic invasion in 3D. (2013). \u3008https:\/\/doi.org\/10.1039\/b000000x\/NIH\u3009.","DOI":"10.1039\/c3ib20196a"},{"key":"10.1016\/j.biopha.2026.119241_bib58","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1529\/biophysj.107.117044","article-title":"Sampling the cell with anomalous diffusion - The discovery of slowness","volume":"94","author":"Guigas","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.biopha.2026.119241_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.trecan.2023.01.001","article-title":"Engine shutdown: migrastatic strategies and prevention of metastases","volume":"9","author":"Raudensk\u00e1","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biopha.2026.119241_bib60","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202255069","article-title":"The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential","volume":"24","author":"Shoji","year":"2023","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biopha.2026.119241_bib61","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1007\/s11033-012-1997-x","article-title":"Cathelicidins: family of antimicrobial peptides. A review","volume":"39","author":"Ko\u015bciuczuk","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2026.119241_bib62","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/pros.21282","article-title":"LL-37 as a therapeutic target for late stage prostate cancer","volume":"71","author":"Hensel","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.biopha.2026.119241_bib63","author":"S\u00f8rensen","year":"2001","journal-title":"Hum. Cathelicidin HCAP18 Is. Process. Antimicrob. Pept. LL37 Extracell. Cleavage Protein 3"},{"key":"10.1016\/j.biopha.2026.119241_bib64","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.8122","article-title":"Activation of TRPV2 and BKCa Channels by the LL-37 Enantiomers Stimulates Calcium Entry and Migration of Cancer Cells","volume":"7","author":"Gambade","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119241_bib65","author":"Johansson","year":"1998","journal-title":"Conform. Depend. Antibact. Act. Nat. Occur. Hum. Pept. LL37*"},{"key":"10.1016\/j.biopha.2026.119241_bib66","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1021\/bi702036s","article-title":"NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles","volume":"47","author":"Porcelli","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2026.119241_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00144","article-title":"The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs","volume":"5","author":"Kuroda","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2026.119241_bib68","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bpj.2009.09.060","article-title":"Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide ll37","volume":"98","author":"Thennarasu","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.biopha.2026.119241_bib69","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1007\/s11033-020-05741-8","article-title":"Human cathelicidin antimicrobial peptide LL-37 promotes lymphangiogenesis in lymphatic endothelial cells through the ERK and Akt signaling pathways","volume":"47","author":"Yanagisawa","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2026.119241_bib70","article-title":"HCAP-18, a Cathelin\/pro-Bactenecin-like Protein of Human Neutrophil Specific Granules","volume":"368","author":"Cowland","year":"1995","journal-title":"FEBS 15706 FEBS Lett."},{"key":"10.1016\/j.biopha.2026.119241_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170311","article-title":"What can we learn about functional importance of human antimicrobial peptide LL-37 in the oral environment from severe congenital neutropenia (Kostmann disease)?","volume":"128","author":"Nilsson","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2026.119241_bib72","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0140-6736(02)11201-3","article-title":"Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study","volume":"360","author":"P\u00fctsep","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119241_bib73","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1158\/1541-7786.MCR-08-0326","article-title":"Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells","volume":"7","author":"Coffelt","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119241_bib74","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2021.12762","article-title":"Antimicrobial peptide 17BIPHE2 inhibits the proliferation of lung cancer cells in vitro and in vivo by regulating the ERK signaling pathway","volume":"22","author":"Yang","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2026.119241_bib75","first-page":"1770","article-title":"Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response","volume":"311","author":"Liu","year":"2006","journal-title":"Science (1979)"},{"key":"10.1016\/j.biopha.2026.119241_bib76","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jsbmb.2014.02.004","article-title":"Regulation of the human cathelicidin antimicrobial peptide gene by 1\u03b1,25-dihydroxyvitamin D3 in primary immune cells","volume":"143","author":"Lowry","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.biopha.2026.119241_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines8030517","article-title":"Immunomodulatory role of the antimicrobial ll-37 peptide in autoimmune diseases and viral infections","volume":"8","author":"Pahar","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2026.119241_bib78","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00011-020-01340-2","article-title":"Human host defense peptide LL-37 facilitates double-stranded RNA pro-inflammatory signaling through up-regulation of TLR3 expression in vascular smooth muscle cells","volume":"69","author":"Dahl","year":"2020","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.biopha.2026.119241_bib79","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cellimm.2010.05.005","article-title":"Effect of the antimicrobial peptide LL-37 on Toll-like receptors 2-, 3- and 4-triggered expression of IL-6, IL-8 and CXCL10 in human gingival fibroblasts","volume":"264","author":"Into","year":"2010","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.biopha.2026.119241_bib80","article-title":"Antimicrobial peptides: mechanism of action, activity and clinical potential","volume":"8","author":"Zhang","year":"2021","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.biopha.2026.119241_bib81","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2174\/0929867326666190805151654","article-title":"Antiviral Activities of Human Host Defense Peptides","volume":"27","author":"Brice","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119241_bib82","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4014\/jmb.2301.01005","article-title":"Understanding the Roles of Host Defense Peptides in Immune Modulation: From Antimicrobial Action to Potential as Adjuvants","volume":"33","author":"Kim","year":"2023","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119241_bib83","article-title":"The Antimicrobial Peptides and Their Potential Clinical Applications","volume":"11","author":"Lei","year":"2019","journal-title":"Am. J. Transl. Res"},{"key":"10.1016\/j.biopha.2026.119241_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/biom14030320","article-title":"LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases","volume":"14","author":"Bhattacharjya","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2026.119241_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512039","article-title":"Insight into the Mechanism of Interactions between the LL-37 Peptide and Model Membranes of Legionella gormanii Bacteria","volume":"24","author":"Pastuszak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119241_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms12071259","article-title":"Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides in the Modern Era: An Updated Review","volume":"12","author":"Tajer","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.biopha.2026.119241_bib87","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bbamem.2015.11.003","article-title":"The human cathelicidin LL-37 - A pore-forming antibacterial peptide and host-cell modulator","volume":"1858","author":"Xhindoli","year":"2016","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.biopha.2026.119241_bib88","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.3390\/ijms22105200","article-title":"Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures","volume":"22","author":"Zeth","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119241_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/biom9090481","article-title":"Sulfated glycoaminoglycans and proteoglycan syndecan-4 are involved in membrane fixation of LL-37 and its pro-migratory effect in breast cancer cells","volume":"9","author":"Habes","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2026.119241_bib90","article-title":"Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119241_bib91","article-title":"LL-37-induced caspase-independent apoptosis is associated with plasma membrane permeabilization in human osteoblast-like cells","volume":"135","author":"Bankell","year":"2021","journal-title":"Pept. (N. Y. )"},{"key":"10.1016\/j.biopha.2026.119241_bib92","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1159\/000490183","article-title":"Roles and mechanisms of human cathelicidin LL-37 in cancer","volume":"47","author":"Chen","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2026.119241_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27154988","article-title":"Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma Cells","volume":"27","author":"Chernov","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119241_bib94","article-title":"The human cathelicidin peptide LL-37 inhibits pancreatic cancer growth by suppressing autophagy and reprogramming of the tumor immune microenvironment","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2026.119241_bib95","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.4049\/jimmunol.1302574","article-title":"Alarmin Function of Cathelicidin Antimicrobial Peptide LL37 through IL-36\u03b3 Induction in Human Epidermal Keratinocytes","volume":"193","author":"Li","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119241_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107529","article-title":"Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease","volume":"210","author":"Miao","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2026.119241_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122747","article-title":"LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy","volume":"14","author":"Stakheev","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119241_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202206936","article-title":"Nanofiber Aerogels with Precision Macrochannels and LL-37-Mimic Peptides Synergistically Promote Diabetic Wound Healing","volume":"33","author":"John","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biopha.2026.119241_bib99","article-title":"LL37 promotes angiogenesis: a potential therapeutic strategy for lower limb ischemic diseases","volume":"16","author":"Yang","year":"2025","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2026.119241_bib100","article-title":"Cathelicidin hCAP18\/LL-37 promotes cell proliferation and suppresses antitumor activity of 1,25(OH)2D3 in hepatocellular carcinoma","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2026.119241_bib101","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.peptides.2016.09.002","article-title":"Molecular mechanisms of LL-37-induced receptor activation: An overview","volume":"85","author":"Verjans","year":"2016","journal-title":"Pept. (N. Y. )."},{"key":"10.1016\/j.biopha.2026.119241_bib102","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400656R","article-title":"LL37\/FPR2 regulates neutrophil mPTP promoting the development of neutrophil extracellular traps in diabetic retinopathy","volume":"38","author":"Lou","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2026.119241_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149513","article-title":"The impact of the P2X7 receptor on the tumor immune microenvironment and its effects on tumor progression","volume":"707","author":"Zou","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119241_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051116","article-title":"The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications","volume":"14","author":"Rotondo","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2026.119241_bib105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.omto.2019.01.004","article-title":"Cathelicidin Suppresses Colon Cancer Metastasis via a P2RX7-Dependent Mechanism","volume":"12","author":"Wang","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.biopha.2026.119241_bib106","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/19336918.2023.2168231","article-title":"Cathelicidin LL-37 promotes EMT, migration and metastasis of hepatocellular carcinoma cells in vitro and mouse model","volume":"17","author":"Zhang","year":"2023","journal-title":"Cell Adh. Migr."},{"key":"10.1016\/j.biopha.2026.119241_bib107","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.4049\/jimmunol.171.12.6690","article-title":"The Antimicrobial Peptide LL-37 Activates Innate Immunity at the Airway Epithelial Surface by Transactivation of the Epidermal Growth Factor Receptor","volume":"171","author":"Tjabringa","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119241_bib108","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ijc.25489","article-title":"Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications","volume":"127","author":"Wu","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119241_bib109","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3390\/molecules21111512","article-title":"The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells","volume":"21","author":"Brenner","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119241_bib110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","article-title":"Signaling pathways and therapeutic interventions in gastric cancer","volume":"7","author":"Lei","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119241_bib111","doi-asserted-by":"crossref","first-page":"78206","DOI":"10.18632\/oncotarget.12151","article-title":"BMP signaling and its paradoxical effects in tumorigenesis and dissemination","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119241_bib112","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119241_bib113","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41392-025-02142-w","article-title":"Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances","volume":"10","author":"Xue","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119241_bib114","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8800.1","article-title":"Actomyosin stress fiber mechanosensing in 2D and 3D","volume":"5","author":"Lee","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.biopha.2026.119241_bib115","author":"Pathak","year":"2012","journal-title":"Indep. Regul. Tumor Cell Migr. Matrix stiffness Confin."},{"key":"10.1016\/j.biopha.2026.119241_bib116","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1091\/mbc.e08-05-0501","article-title":"Epidermal Growth Factor\u2013induced Enhancement of Glioblastoma Cell Migration in 3D Arises from an Intrinsic Increase in Speed But an Extrinsic Matrix- and Proteolysis-dependent Increase in Persistence","volume":"19","author":"Kim","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.biopha.2026.119241_bib117","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-016-0787-y","article-title":"CD24 associates with EGFR and supports EGF\/EGFR signaling via RhoA in gastric cancer cells","volume":"14","author":"Deng","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119241_bib118","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.175.7.4662","article-title":"Induction of Keratinocyte Migration via Transactivation of the Epidermal Growth Factor Receptor by the Antimicrobial Peptide LL-37","volume":"175","author":"Tokumaru","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119241_bib119","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1039\/C7MB00390K","article-title":"Quantitative investigation of MDA-MB-231 breast cancer cell motility: Dependence on epidermal growth factor concentration and its gradient","volume":"13","author":"Islam","year":"2017","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.biopha.2026.119241_bib120","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1096\/fj.201600252","article-title":"Immobilized epidermal growth factor stimulates persistent, directed keratinocyte migration via activation of PLC\u03b31","volume":"30","author":"Kim","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2026.119241_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1258119","article-title":"Time-resolved role of P2X4 and P2X7 during CD8+ T cell activation","volume":"15","author":"Brock","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119241_bib122","doi-asserted-by":"crossref","first-page":"30471","DOI":"10.1074\/jbc.M802185200","article-title":"The human cathelicidin LL-37 modulates the activities of the P2X 7 receptor in a structure-dependent manner","volume":"283","author":"Tomasinsig","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119241_bib123","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1074\/jbc.M109.090746","article-title":"Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK)","volume":"285","author":"Chan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119241_bib124","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1245\/s10434-021-11132-5","article-title":"TRPV2 Promotes Cell Migration and Invasion in Gastric Cancer via the Transforming Growth Factor-\u03b2 Signaling Pathway","volume":"29","author":"Kato","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.biopha.2026.119241_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064885","article-title":"TRPV2 Mediates Adrenomedullin Stimulation of Prostate and Urothelial Cancer Cell Adhesion, Migration and Invasion","volume":"8","author":"Oulidi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2026.119241_bib126","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41374-019-0333-7","article-title":"The TRPV2 cation channels: from urothelial cancer invasiveness to glioblastoma multiforme interactome signature","volume":"100","author":"Santoni","year":"2020","journal-title":"Lab. Investig."},{"key":"10.1016\/j.biopha.2026.119241_bib127","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000092305","article-title":"Human cathelicidin LL-37 Is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors","volume":"140","author":"Tjabringa","year":"2006","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.biopha.2026.119241_bib128","article-title":"The G-Protein Coupled Chemoattractant Receptor FPR2 Promotes Malignant Phenotype of Human Colon Cancer Cells","volume":"6","author":"Xiang","year":"2016","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.biopha.2026.119241_bib129","doi-asserted-by":"crossref","DOI":"10.1084\/jem.192.7.1069","article-title":"LL-37, the Neutrophil Granule-and Epithelial Cell-Derived Cathelicidin, Utilizes Formyl Peptide Receptor-like 1 (FPRL1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells","volume":"192","author":"Yang","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2026.119241_bib130","volume":"105","author":"Dieterich","year":"2008","journal-title":"Anomalous Dyn. Cell Migr."},{"key":"10.1016\/j.biopha.2026.119241_bib131","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3892\/mmr.2016.5978","article-title":"Antimicrobial peptide LL-37 promotes YB-1 expression, and the viability, migration and invasion of malignant melanoma cells","volume":"15","author":"Jia","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2026.119241_bib132","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1365-2133.2010.09957.x","article-title":"The antimicrobial peptide human cationic antimicrobial protein-18\/ cathelicidin LL-37 as a putative growth factor for malignant melanoma","volume":"163","author":"Kim","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2026.119241_bib133","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3892\/ol.2016.4865","article-title":"Antimicrobial peptide LL-37 promotes the proliferation and invasion of skin squamous cell carcinoma by upregulating DNA-binding protein A","volume":"12","author":"Wang","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2026.119241_bib134","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3892\/etm.2017.4546","article-title":"Antimicrobial peptide LL-37 promotes the viability and invasion of skin squamous cell carcinoma by upregulating YB-1","volume":"14","author":"Wang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2026.119241_bib135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3892\/or.2020.7609","article-title":"Fluctuating role of antimicrobial peptide hCAP18\/LL-37 in oral tongue dysplasia and carcinoma","volume":"44","author":"Vierthaler","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2026.119241_bib136","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2026.119241_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050688","article-title":"Functional implications of cathelicidin antimicrobial protein in breast cancer and tumor-associated macrophage microenvironment","volume":"10","author":"Chen","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2026.119241_bib138","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1016\/j.bbadis.2018.09.008","article-title":"Overexpression of CXCR4 synergizes with LL-37 in the metastasis of breast cancer cells","volume":"1864","author":"Pan","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2026.119241_bib139","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2221","article-title":"Human antimicrobial protein hCAP18\/LL-37 promotes a metastatic phenotype in breast cancer","volume":"11","author":"Weber","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.biopha.2026.119241_bib140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1021\/cb400789e","article-title":"The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains","volume":"9","author":"Dittmann","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biopha.2026.119241_bib141","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BJ20061489","article-title":"Exploring the specificity of the PI3K family inhibitor LY294002","volume":"404","author":"Gharbi","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2026.119241_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2024.102874","article-title":"Ruthenium red: Blocker or antagonist of TRPV channels?","volume":"119","author":"Jara-Oseguera","year":"2024","journal-title":"Cell Calcium"},{"key":"10.1016\/j.biopha.2026.119241_bib143","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/ajco.13873","article-title":"Epirubicin may enhance the inhibition of hepatocellular carcinoma induced by iodine-125 seeds through downregulating WNT pathway","volume":"19","author":"Tian","year":"2023","journal-title":"Asia. Pac. J. Clin. Oncol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600274X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600274X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:47:11Z","timestamp":1779245231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222600274X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":143,"alternative-id":["S075333222600274X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119241","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer cell migration under control of human cathelicidin LL-37","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119241"}}